Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Progress in immunosuppression].

C P Strassburg1, M J Bahr, T Becker

  • 1Klinik für Gastroenterologie, Hepatologie und Endokrinologie, Medizinische Hochschule Hannover, Carl-Neuberg-Strasse 1, 30625 Hannover. strassburg.christian@mh-hannover.de

Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen
|January 23, 2008
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The challenge of replicating putative genetic risk factors in a population-based database.

Journal of gastroenterology and hepatology·2024
Same author

Phase Ib study of talimogene laherparepvec in combination with atezolizumab in patients with triple negative breast cancer and colorectal cancer with liver metastases.

ESMO open·2023
Same author

TLR agonists enhance responsiveness of inflammatory innate immune cells in HLA-B*57-positive HIV patients.

Journal of molecular medicine (Berlin, Germany)·2020
Same author

Dye chromoendoscopy leads to a higher adenoma detection in the duodenum and stomach in patients with familial adenomatous polyposis.

Endoscopy international open·2020
Same author

Parameters predicting COVID-19-induced myocardial injury and mortality.

Life sciences·2020
Same author

Consensus on definition and severity grading of lymphatic complications after kidney transplantation.

The British journal of surgery·2020
Same journal

[S3 Guideline "Adult soft tissue sarcomas"].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Synopsis-S3 guidelines pancreatic cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Laparoscopic sentinel node navigation surgery in gastric cancer to reduce surgical radicality].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Future concepts for neoadjuvant and adjuvant treatment of (resectable) pancreatic cancer].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[ASCO guidelines for the treatment of stage III NSCLC part 4: indications for adjuvant therapy].

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
Same journal

[Surgical treatment of pancreatic cancer-What is new?]

Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen·2022
See all related articles

Optimizing immunosuppression is key for successful organ transplants. Modern strategies combine drugs to reduce side effects and improve long-term patient outcomes.

Area of Science:

  • Immunology
  • Transplantation Medicine
  • Pharmacology

Context:

  • Successful organ transplantation relies heavily on managing iatrogenic immunosuppression.
  • Liver transplantation commonly uses calcineurin inhibitors and steroids as foundational immunosuppression.
  • Balancing efficacy and side effects, particularly nephrotoxicity, is crucial for patient management.

Purpose:

  • To review the evolution and current strategies in immunosuppression for organ transplantation.
  • To highlight the shift towards minimizing steroid toxicity and nephrotoxicity.
  • To discuss the integration of novel agents and tolerance induction.

Summary:

  • Immunosuppression management has advanced from basic calcineurin inhibitors and steroids to include antimetabolites like mycophenolate and reduced calcineurin inhibitor doses.

Related Experiment Videos

  • The 1990s saw the introduction of specific antibodies and induction protocols, allowing delayed calcineurin inhibitor use and fewer side effects.
  • Current progress involves combining synergistic immunosuppressants for diverse indications, from viral infections to tumors, with ongoing research into tolerance induction.

    • Impact:

    • Improved long-term outcomes and reduced side effects in transplant recipients.
    • Enhanced clinical management protocols for transplanted patients with various underlying conditions.
    • Development of novel immunosuppressive drugs and tolerance strategies for future transplantation practices.